Flu :: Health Canada approves cold and flu medicine
Health Canada, the Canadian government regulatory agency, has approved wide-ranging new health claims for COLD-fX, the most popular cold/flu remedy in Canada.
Health Canada, the Canadian government regulatory agency, has approved wide-ranging new health claims for COLD-fX, the most popular cold/flu remedy in Canada.
In hospitals today, the first warning that a post-operative patient is going into septic shock is often when the patient’s blood pressure collapses and congestive heart failure begins. By that time the patient has a high probability of dying, or if he survives, an even higher probability of permanent major organ damage after a long stay in an intensive care unit.
Proacta Therapeutics, a spin-out company of The University of Auckland, has raised US$35 million (NZ$51 million) in venture capital to continue its research into potential treatments for cancer.
Standing with the CEOs of Fortune 500 companies and national labor and civic leaders, SEIU helped launch a historic, new cooperative effort with the goal of fundamentally changing the nation?s broken health care system.
Physicians who treat a blood disorder called idiopathic thrombocytopenic purpura (ITP), characterized by easy bruising and excessive bleeding, now have a new tool to help them provide the best care for patients with this disease.
The International AIDS Vaccine Initiative’s (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006. There are now more than 30 trials ongoing in 24 countries, across every continent.
South Dakota businessman Denny Sanford has set a new standard in healthcare philanthropy with an unprecedented gift of $400 million to Sioux Valley Hospitals & Health System.
A research team led by Prof. Claude Perreault, Universit? de Montr?al, is announcing a major discovery in Genomics. This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts.
Researchers at the University of Alberta, in Edmonton, Canada, have announced the completion of the first draft of the human metabolome, the chemical equivalent of the human genome.
On the morning of Friday, January 26, 2007, we invite you to celebrate with us a momentous event in the histories of Weill Cornell Medical College and the medical community of New York City. The presentation will include the opening of the new 13-story, 300,000-square-ft. Ambulatory Care and Medical Education Building along with the formal naming of the building.